Chemoinformaics analysis of Austrobailignan-7
| Molecular Weight | 342.391 | nRot | 3 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 21 |
| Exact Molecular Weight | 342.147 | nRing | 4 |
| Solubility: LogS | -5.26 | nHRing | 2 |
| Solubility: LogP | 4.38 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 52.0794 |
| nHD | 1 | BPOL | 29.0146 |
| QED | 0.905 |
| Synth | 3.487 |
| Natural Product Likeliness | 1.091 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.729 |
| MDCK | 0.0000515 |
| BBB | 0.132 |
| PPB | 0.966112 |
| VDSS | 1.61 |
| FU | 0.0204805 |
| CYP1A2-inh | 0.721 |
| CYP1A2-sub | 0.824 |
| CYP2c19-inh | 0.966 |
| CYP2c19-sub | 0.465 |
| CYP2c9-inh | 0.906 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.942 |
| CYP2d6-sub | 0.911 |
| CYP3a4-inh | 0.961 |
| CYP3a4-sub | 0.538 |
| CL | 17.937 |
| T12 | 0.164 |
| hERG | 0.112 |
| Ames | 0.43 |
| ROA | 0.076 |
| SkinSen | 0.79 |
| Carcinogencity | 0.831 |
| EI | 0.825 |
| Respiratory | 0.906 |
| NR-Aromatase | 0.329 |
| Antiviral | Yes |
| Prediction | 0.520756 |